RHELION LIFE SCIENCES CORP (TRUFF:OTCMKTS)

$0.0256 0.0023 (9.8712%)

watchlist-icon
search-icon
Profile Icon

Most Recent Average Sentiment Analysis Score (0 to 100): 67

negative-sentiment
Negative [0, 35)
neutral-sentiment
Neutral [35, 65]
positive-sentiment
Positive (65, 100]
Visualize Sentiment Trendline

Analysed RHELION LIFE SCIENCES CORP (TRUFF:OTCMKTS) News Sources

Rhelion Life Sciences Announces Appointment of Samiuddin Khaja as CFO

19-08-2026

yahoo.com

Rhelion Life Sciences' Wholly Owned Subsidiary Filament Health Signs Letter of Intent with Darmiyan, Inc. to Explore Use of FDA De Novo Authorized BrainSee(R) AI Platform in Early Alzheimer's Disease Trial Design

20-08-2026

yahoo.com

Rhelion Life Sciences Wholly Owned Subsidiary Filament Health Completes Shipment of PEX010 for University of Washington Phase 2a Trial in Cancer-Related Anxiety and Depression

25-08-2026

yahoo.com

Rhelion Life Sciences' Wholly Owned Subsidiary Filament Health Issued New United States Patent, Extending the Broadest Natural Psilocybin Patent Estate

27-08-2026

yahoo.com

Rhelion Life Sciences Reports First Quarter 2027 Results

31-08-2026

yahoo.com

Rhelion Life Sciences Confirms Further Delivery of Filament Health's PEX010 to Germany's First Psilocybin Compassionate Use Program

03-09-2026

yahoo.com

Rhelion Life Sciences' Wholly Owned Subsidiary Filament Health Completes Shipment of PEX010 to Australia for University of Melbourne Trial of Psilocybin-Assisted Physiotherapy in Functional Neurological Disorder

08-09-2026

yahoo.com

Rhelion Life Sciences Announces Filament Health is Planning a Stability Program for IBEX011, Its Naturally Derived Ibogaine Drug Candidate

10-09-2026

yahoo.com

Rhelion Life Sciences' Wholly Owned Subsidiary Filament Health to Deliver Oral Comments at FDA Public Hearing on the Potential Future Therapeutic Use of Psychedelic Drugs

14-09-2026

yahoo.com

Rhelion Life Sciences Wholly Owned Subsidiary Filament Health Signs Supply and Licensing Agreement with the University of Southern California for PEX010 in a Trial for Psilocybin-Assisted Mindfulness Therapy

15-09-2026

yahoo.com

RHELION LIFE SCIENCES CORP (TRUFF:OTCMKTS) Sentiment Trend

0 25 50 75 100 58 86 65 74 63 55 67 68 64 69 19-08-2026 20-08-2026 25-08-2026 27-08-2026 31-08-2026 03-09-2026 08-09-2026 10-09-2026 14-09-2026 15-09-2026 #1 #2 #3 #4 #5 #6 #7 #8 #9 #10 Negative < 35 Neutral 35–65 Positive > 65 View FAQ

RHELION LIFE SCIENCES CORP (TRUFF:OTCMKTS) FAQs

toggle

What is the current price of RHELION LIFE SCIENCES CORP (TRUFF:OTCMKTS)?

The current price of RHELION LIFE SCIENCES CORP (TRUFF:OTCMKTS) is $0.0256.


toggle

RHELION LIFE SCIENCES CORP (TRUFF:OTCMKTS) absolute price change since previous trading day?

The absolute price change of RHELION LIFE SCIENCES CORP (TRUFF:OTCMKTS) since the previous trading day is $0.0023.


toggle

RHELION LIFE SCIENCES CORP (TRUFF:OTCMKTS) percentage price change since previous trading day?

The percentage price change of RHELION LIFE SCIENCES CORP (TRUFF:OTCMKTS) since the previous trading day is 9.8712%.


toggle

What is the most recent average sentiment score for RHELION LIFE SCIENCES CORP (TRUFF:OTCMKTS)?

The most recent average sentiment score for RHELION LIFE SCIENCES CORP (TRUFF:OTCMKTS) is 67 out of 100.


toggle

What is the most recent average sentiment for RHELION LIFE SCIENCES CORP (TRUFF:OTCMKTS)?

The most recent sentiment for RHELION LIFE SCIENCES CORP (TRUFF:OTCMKTS) is .


SEC-8K** Filing Available For RHELION LIFE SCIENCES CORP (TRUFF:OTCMKTS)

** material developments that could impact a company's financial condition or stock price.

Author: MattELab

X Icon

GitHub Icon

MattELab is the founder and lead developer of SentientMerchant. With a Computer Science and Quantitative Finance background from a T10 university, he brings over 6 years of expertise in NLP, programmatic SEO, and full-stack development to build highly scalable AI and FinTech solutions.